Halozyme Therapeutics, Inc.

STEPHENS INC /AR/ HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/5/2026

Shares

4,062

Value ($000)

273

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/5/2026	273	0.0%	4,062	12/31/2025
2025 Q3	10/27/2025	305	0.0%	4,157	9/30/2025
2025 Q2	7/29/2025	271	0.0%	5,207	6/30/2025
2025 Q1	5/1/2025	348	0.0%	5,451	3/31/2025
2024 Q4	1/28/2025	261	0.0%	5,464	12/31/2024
2024 Q3	10/28/2024	392	0.0%	6,841	9/30/2024
2024 Q2	8/6/2024	481	0.0%	9,183	6/30/2024
2024 Q1	5/15/2024	375	0.0%	9,219	3/31/2024
2023 Q4	2/13/2024	232	0.0%	6,289	12/31/2023
2023 Q3	11/14/2023	234	0.0%	6,130	9/30/2023
2023 Q2	8/14/2023	212	0.0%	5,875	6/30/2023
2023 Q1	5/15/2023	112	0.0%	2,922	3/31/2023
2022 Q4	2/14/2023	165	0.0%	2,899	12/31/2022
2022 Q3	11/2/2022	115	0.0%	2,899	9/30/2022
2022 Q2	8/3/2022	128	0.0%	2,899	6/30/2022
2022 Q1	5/4/2022	116	0.0%	2,899	3/31/2022
2021 Q4	3/7/2022	102	0.0%	2,530	12/31/2021
2021 Q3	10/27/2021	103	0.0%	2,530	9/30/2021
2021 Q2	8/12/2021	115	0.0%	2,530	6/30/2021
2021 Q1	5/14/2021	105	0.0%	2,530	3/31/2021
2020 Q4	2/10/2021	23	0.0%	530	12/31/2020
2020 Q3	11/13/2020	82	0.0%	3,133	9/30/2020
2020 Q2	8/24/2020	107	0.0%	4,000	6/30/2020